ArticlePDF AvailableLiterature Review

Nuttall FQ, Gannon MC. Metabolic response of people with type 2 diabetes to a high protein diet. Nutr Metab (London) 1, 6

Authors:

Abstract and Figures

Background One of the major interests in our laboratory has been to develop a scientific framework for dietary advice for patients with diabetes. Knowledge regarding the metabolic consequences and potential effects on health of protein in people with type 2 diabetes has been a particular interest. Results We recently have completed a study in which dietary protein was increased from 15% to 30% of total food energy. The carbohydrate content was decreased from 55% to 40%, i.e. dietary protein replaced part of the carbohydrate. This resulted in a significant decrease in total glycohemoglobin, a decrease in postprandial glucose concentrations and a modest increase in insulin concentration. Renal function was unchanged. Currently we also are determining the metabolic response to a diet in which the carbohydrate content is further decreased to 20% of total food energy. The %tGHb decrease was even more dramatic than with the 40% carbohydrate diet. Conclusion From these data we conclude that increasing the protein content of the diet at the expense of carbohydrate can reduce the 24-hour integrated plasma glucose concentration, at least over a 5-week period of time. The reduction was similar to that of oral agents. Renal function was not affected significantly. Thus, increasing the protein content of the diet with a corresponding decrease in the carbohydrate content potentially is a patient empowering way of reducing the hyperglycemia present with type 2 diabetes mellitus, independent of the use of pharmaceutical agents.
Content may be subject to copyright.
BioMed Central
Page 1 of 7
(page number not for citation purposes)
Nutrition & Metabolism
Open Access
Review
Metabolic response of people with type 2 diabetes to a high protein
diet
Frank Q Nuttall*
†1,2
and Mary C Gannon
†1,2,3
Address:
1
Metabolic Research Laboratory, Endocrine, Metabolism & Nutrition Section, Minneapolis VA Medical Center, Minneapolis, USA,
2
Department of Medicine, University of Minnesota, USA and
3
Department of Food Science and Nutrition, University of Minnesota, USA
Email: Frank Q Nuttall* - nutta001@umn.edu; Mary C Gannon - ganno004@umn.edu
* Corresponding author †Equal contributors
Abstract
Background: One of the major interests in our laboratory has been to develop a scientific
framework for dietary advice for patients with diabetes. Knowledge regarding the metabolic
consequences and potential effects on health of protein in people with type 2 diabetes has been a
particular interest.
Results: We recently have completed a study in which dietary protein was increased from 15% to
30% of total food energy. The carbohydrate content was decreased from 55% to 40%, i.e. dietary
protein replaced part of the carbohydrate. This resulted in a significant decrease in total
glycohemoglobin, a decrease in postprandial glucose concentrations and a modest increase in
insulin concentration. Renal function was unchanged.
Currently we also are determining the metabolic response to a diet in which the carbohydrate
content is further decreased to 20% of total food energy. The %tGHb decrease was even more
dramatic than with the 40% carbohydrate diet.
Conclusion: From these data we conclude that increasing the protein content of the diet at the
expense of carbohydrate can reduce the 24-hour integrated plasma glucose concentration, at least
over a 5-week period of time. The reduction was similar to that of oral agents. Renal function was
not affected significantly. Thus, increasing the protein content of the diet with a corresponding
decrease in the carbohydrate content potentially is a patient empowering way of reducing the
hyperglycemia present with type 2 diabetes mellitus, independent of the use of pharmaceutical
agents.
Background
Our research group has been and continues to be inter-
ested in the metabolic response of people with type 2 dia-
betes to macronutrients in the diet in general. More
recently, we have been particularly focused on the meta-
bolic response to a high protein diet. The reason for this is
three fold: First, for several years, one of our major goals
has been to develop a scientific framework for dietary
advice based on sound metabolic principles. Second, we
have data that suggest that an increase in dietary protein
may be salutary for people with diabetes. And lastly,
knowledge regarding the metabolic consequences and
potential effects on health of dietary protein has lagged far
behind that of dietary fats and carbohydrates.
Published: 13 September 2004
Nutrition & Metabolism 2004, 1:6 doi:10.1186/1743-7075-1-6
Received: 03 August 2004
Accepted: 13 September 2004
This article is available from: http://www.nutritionandmetabolism.com/content/1/1/6
© 2004 Nuttall and Gannon; licensee BioMed Central Ltd.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0
),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Nutrition & Metabolism 2004, 1:6 http://www.nutritionandmetabolism.com/content/1/1/6
Page 2 of 7
(page number not for citation purposes)
In this paper we will focus on the concept that an increase
in dietary protein may be salutary for people with diabe-
tes, and particularly for the control of blood glucose.
Results
The concept that an increase in dietary protein may be
useful in controlling the blood glucose would appear to
be counterintuitive, since amino acids derived from
ingested or endogenous proteins are major net gluconeo-
genic substrates.
The first step in the metabolism of amino acids is the
removal of the amino group. This is condensed with CO
2
to form urea. The remaining deaminated product is
largely converted into glucose through gluconeogenesis,
although a small amount is converted into other prod-
ucts. (Figure 1).
Indeed, in 1915, Dr. Janney [1] reported that 3.5 g glucose
can be obtained from 6.25 g of ingested meat or beef pro-
tein. Thus, theoretically for every 100 g of protein
ingested, 56 g of glucose can be produced. For other pro-
teins this varies between 50 and 84 grams. Thus when
developing a dietary regimen for diabetic patients, dieti-
tians were taught to count not only carbohydrate, but also
to count 56% of the protein as carbohydrate. The ration-
ale behind this recommendation was that carbohydrates
raised blood glucose, proteins are converted to glucose,
therefore, dietary proteins will raise blood glucose.
However, in 1924, Dr. MacLean [2] reported that when a
man with diabetes, and a fasting blood glucose of 280
mg/dl, ingested 250 g of meat, which is the equivalent of
50 grams of protein, and which should result in the
production of ~25 g of glucose, there was no change in
blood glucose over the 5 hours of the study. When the
same subject ingested 25 g of glucose, there was a very
large increase in blood glucose; indeed, it increased up to
600 mg/dl.
This lack of increase in blood glucose concentration fol-
lowing the ingestion of protein was confirmed by Conn
and Newburgh in 1936 [3]. These investigators fed a rela-
tively enormous amount of beef, i.e. 1.3 pounds of beef,
which is the equivalent of ~136 g of protein and which
should yield 68 g of glucose, to a normal subject with a
fasting blood glucose of 65 mg/dl and to a subject with
diabetes whose fasting blood glucose concentration was
150 mg/dl. In neither case was there an increase in blood
glucose concentration over the 8 hours of this study. How-
ever, when the same subjects were given 68 g of glucose,
there clearly was an increase in glucose concentration in
both cases.
That ingested protein did not raise the blood glucose was
largely ignored, in spite of this evidence in the scientific
literature. Indeed, in his textbook in 1945 [4], Dr. Joslin,
one of the most influential diabetologists at that time, was
still counseling dietitians and patients to consider 56% of
dietary protein as if it were carbohydrate.
Single meal studies done in our laboratory
With this background information, we decided to do a
study expanding on these early observations. Seven sub-
jects with type 2 diabetes [5], and 8 subjects without dia-
betes [6] ingested 50 g of protein in the form of very lean
beef. In the non-diabetic subjects, there was no change in
blood glucose concentration over the 4 hours of the study,
as had been noted previously. However, in the subjects
with type 2 diabetes, the glucose concentration actually
decreased over the 5 hours of that study (Figure 2).
We also determined the serum insulin response to the
ingested protein and in confirmation of the studies of
Berger [7], Fajans [8] and others, we observed a modest
increase in the insulin concentration in the non-diabetic
subjects [6]. However, there was a relatively large increase
in insulin concentration in the subjects with type 2 diabe-
tes [5]. Indeed, it was about four-fold greater than in the
non-diabetic subjects (Figure 2). We also determined that
the rise in insulin following the ingestion of 50 g of beef
protein was just as potent in raising the insulin concentra-
tion as was the ingestion of 50 g of glucose [5]. That is,
meat protein and glucose were equipotent in stimulating
insulin secretion. In addition, we also demonstrated a
The α amino group from an amino acid is condensed with CO
2
to form ureaFigure 1
The α amino group from an amino acid is condensed
with CO
2
to form urea. The remaining carbon skeleton
can be used to synthesize glucose.
Nutrition & Metabolism 2004, 1:6 http://www.nutritionandmetabolism.com/content/1/1/6
Page 3 of 7
(page number not for citation purposes)
linear dose-response relationship between the amount of
beef ingested and the insulin response [5].
Since beef protein strongly stimulated insulin secretion,
we next determined whether the simultaneous ingestion
of protein with glucose would stimulate even more insu-
lin and thus reduce the rise in glucose expected when glu-
cose alone is ingested. We also were interested in
determining if all common protein sources were equal in
this regard. Therefore, we designed a study in which 9 – 15
males with untreated type 2 diabetes were given 50 g of
glucose with or without 25 g of protein [9]. Seven protein
sources were used: beef, turkey, gelatin, egg white, cottage
cheese, fish and soy. The rationale behind giving 25 g of
protein with 50 g of glucose, was that this ratio more
closely resembles the ratio of protein to carbohydrate typ-
ically found in the diet. The plasma glucose and serum
insulin concentrations were determined over a 5-hour
period and the areas under the curves were calculated.
The glucose area response clearly was decreased when glu-
cose was ingested with 25 g of protein as beef, turkey, gel-
atin, cottage cheese, fish and soy. Only egg white did not
result in a significant decrease in glucose area response
when compared to the response to ingestion of glucose
alone (Figure 3).
When any of the proteins was added to the ingested glu-
cose, the insulin area response was greatly increased (Fig-
ure 4). The smallest response was obtained with egg
white, which was 190% or 1.9 fold over the response to
glucose ingested alone. The greatest increase was with cot-
tage cheese, which was 360% or 3.6 fold.
As indicated previously, beef protein, on a weight basis,
was just as potent as glucose in raising the insulin concen-
tration. Since only 25 g of beef protein was ingested in the
present study, the expected response would be 150% of
that observed with just glucose ingestion [5]. With beef
and every other protein source studied, the insulin
response was greater than the theoretical expected
response (Figure 4), strongly suggesting that there is a syn-
ergistic insulin response when protein is ingested with
glucose [9].
In summary, in single meal studies in people with type 2
diabetes, dietary protein strongly stimulated insulin
secretion and decreased the plasma glucose response to
ingested glucose.
Insulin and Glucose Response to Mixed Meals
Based on the above observations, we decided to deter-
mine whether an increase in dietary protein in association
with a decrease in carbohydrate would decrease the 24
hour integrated plasma glucose concentration, increase
the 24 hour integrated insulin concentration and decrease
the % total glycohemoglobin in people with type 2
diabetes ingesting mixed meals over an extended period
of time.
Glucose (left panel) and insulin (right panel) response to ingestion of 50 g of protein in the form of lean beefFigure 2
Glucose (left panel) and insulin (right panel) response
to ingestion of 50 g of protein in the form of lean
beef. Data from 8 non-diabetic subjects (white lines, bot-
tom) and 7 subjects with type 2 diabetes (yellow lines, top).
(From [5,6])
Five hour integrated glucose area response to ingestion of 50 g glucose alone (pink bar) or 50 g glucose + 25 g protein in the form of beef, turkey, gelatin, egg white, cottage cheese, fish or soy (yellow bars, left to right)Figure 3
Five hour integrated glucose area response to inges-
tion of 50 g glucose alone (pink bar) or 50 g glucose +
25 g protein in the form of beef, turkey, gelatin, egg
white, cottage cheese, fish or soy (yellow bars, left to
right). (From [9])
Nutrition & Metabolism 2004, 1:6 http://www.nutritionandmetabolism.com/content/1/1/6
Page 4 of 7
(page number not for citation purposes)
We designed a study in which the protein content of the
diet was increased from 15% of total food energy in a
standard diet, to 30% protein in the experimental diet
[10]. The carbohydrate content was decreased from 55%
carbohydrate to 40% carbohydrate. However, it should be
understood that since the additional protein can result in
an increase in glucose production, the actual carbohydrate
available theoretically would be about 48%, or a decrease
in potential carbohydrate of only 7%. The fat content
remained the same in both diets. Monounsaturated, pol-
yunsaturated and saturated fat ratios were 10:10:10,
respectively.
Twelve people with untreated type 2 diabetes were studied
using a randomized, crossover design. The subjects
received each diet for 5 weeks with a washout period in
between. The diets were isocaloric, and all food was pro-
vided. The subjects came to the Special Diagnostic and
Treatment Unit 2–3 times each week to pick up the food,
to be weighed, and to provide a urine specimen for creat-
inine and urea nitrogen determination.
The major end-point of the study was to determine if there
was a significant decrease in % total glycohemoglobin
(%tGHb).
The reason that 5 weeks was chosen for the study is
because this is the time required for the % total glycohe-
moglobin to decrease 50% of its ultimate value after a
rapid stable decrease in blood glucose concentration (Fig-
ure 5), [11], i.e. the results obtained should represent 50%
of the ultimate % total glycohemoglobin response.
The subjects were weight stable on both diets. We consid-
ered this to be a very important aspect of the study
because we wanted to attribute any metabolic changes to
the diet per se, and not to be confounded by weight loss
(or gain) [10].
Urine urea, normalized to the urine creatinine, was meas-
ured as an index of compliance. Since the protein content
of the diet was doubled, one would expect that the urine
urea:creatinine ratio also would approximately double if
the subjects were compliant. The ratio on the standard
diet was ~7 and was stable throughout the 5 weeks. When
the same subjects were given the 30% protein diet, the
urine urea:creatinine ratio was ~13–14, i.e. a value that
one would expect with good compliance with the diet.
The fasting glucose concentration did not change when
the subjects received the 30% protein diet. However, the
postprandial glucose concentrations were lower through-
out the day [10].
Although the differences in postprandial glucose values
were not very large, when integrated over the 24-hour
period, there was a 38% decrease in postprandial glucose
area response. If the 24-hour integrated area is considered
to be 100% when the subjects ingested the 15% protein
diet, when they ingested the 30% protein diet it was 62%
(Figure 6).
Five hour integrated insulin area response to ingestion of 50 g glucose alone (pink bar) or 50 g glucose + 25 g protein in the form of beef, turkey, gelatin, egg white, cottage cheese, fish or soy (yellow bars, left to right)Figure 4
Five hour integrated insulin area response to inges-
tion of 50 g glucose alone (pink bar) or 50 g glucose +
25 g protein in the form of beef, turkey, gelatin, egg
white, cottage cheese, fish or soy (yellow bars, left to
right). The horizontal line indicates the expected insulin
area response. (From [9])
Rate of change in % tGHbFigure 5
Rate of change in % tGHb
Nutrition & Metabolism 2004, 1:6 http://www.nutritionandmetabolism.com/content/1/1/6
Page 5 of 7
(page number not for citation purposes)
Even though the postprandial glucose concentration was
decreased on the 30% protein diet, the insulin area
response was modestly increased (Figure 7).
The % total glycohemoglobin decreased slightly from 8%
to 7.7% during the 5 weeks of the study when the subjects
were ingesting the 15% protein diet. When the subjects
ingested the 30% protein diet, it decreased from 8.1 to
7.3%, i.e. the decrease was 0.8 (Figure 8).
To put this decrease in % glycohemoglobin into perspec-
tive, the Physicians Desk Reference for 2003 [12] was
consulted in regard to the decrease in %HbA1c or
%glycohemoglobin when subjects with type 2 diabetes
were given rosiglitazone or metformin, drugs commonly
used to treat people with type 2 diabetes. In subjects
receiving 4 mg rosiglitazone twice a day, which is a
maximal dose, the mean decrease in HbA1c was 0.7%
over a 16-week period of time (Table 1). For metformin,
at a maximum dose of 2500 mg daily, the decrease was
1.4% over a 29-week period.
With the 30% protein diet, the decrease was 0.8% over the
5 weeks of our study. The ultimate decrease could be
1.6%, since at 5 weeks (35 days) the %tGHb would have
decreased by only 50% of the expected final decrease (see
Figure 5). Thus, the decrease would be similar to that
obtained using either of the above two medications.
Since there has been concern that a high protein diet may
impair renal function, the creatinine clearance was deter-
mined at the end of the period of time the subjects
ingested the 15% protein diet and at the end of the period
of time that the subjects ingested the 30% protein diet.
There was essentially no difference. The microalbumin
excretion also did not change (Table 2).
Also the differences in total cholesterol, HDL-cholesterol,
LDL-cholesterol were not significant. The fasting
triacylglycerol concentration decreased significantly when
the subjects were on the 30% protein diet (Table 3).
24-hr integrated plasma glucose area response in 12 subjects with type 2 diabetes after ingesting the 15% protein or the 30% protein diet for 5 weeksFigure 6
24-hr integrated plasma glucose area response in 12
subjects with type 2 diabetes after ingesting the 15%
protein or the 30% protein diet for 5 weeks. (From
[10])
24-hr integrated serum insulin area response in 12 subjects with type 2 diabetes after ingesting the 15% or the 30% pro-tein diet for 5 weeksFigure 7
24-hr integrated serum insulin area response in 12
subjects with type 2 diabetes after ingesting the 15%
or the 30% protein diet for 5 weeks. (From [10])
Nutrition & Metabolism 2004, 1:6 http://www.nutritionandmetabolism.com/content/1/1/6
Page 6 of 7
(page number not for citation purposes)
Discussion
In summary, the integrated postprandial glucose area
response was 38% less following ingestion of the 30%
compared to the 15% protein diet. Total glycohemo-
globin decreased significantly from 8.1 to 7.3% and
potentially could result in a decrease to 6.5%. The
integrated insulin concentration increased modestly.
Renal function, LDL, HDL, and total cholesterol were
unchanged. The triacylglycerol concentration decreased.
Conclusions
From these data we conclude that increasing the protein
content of the diet at the expense of carbohydrate can
reduce the 24-hour integrated plasma glucose concentra-
tion, at least over a 5-week period of time. The reduction
was similar to that of oral agents and renal function was
not affected significantly. Thus, increasing the protein
content of the diet with a corresponding decrease in the
carbohydrate content potentially is a patient empowering
way of reducing the hyperglycemia present in people with
type 2 diabetes mellitus, independent of the use of phar-
maceutical agents.
Results of a further modification in macronutrient content
More recently we have completed study comparing an
experimental diet to the standard diet, over a 5-week
period of time. In the experimental diet, the protein was
increased from 15% to 30% as in the above study. How-
ever, in this study the carbohydrate content was decreased
from 55% to 20% of total food energy and the fat content
was increased from 30% to 50%. The subjects studied
were people with untreated type 2 diabetes. It was a
weight maintenance diet, with a randomized crossover
design. The %tGHb decrease was even more dramatic (9.8
to 7.6%) [13].
Table 1: Comparison of treatment
Agent Dose Duration of Treatment Decrease in %tGHb or %HbA1c
Rosiglitizone 4 mg bid 16 weeks 0.7%
Metformin 2500 mg 29 weeks 1.4%
30% Protein Diet 5 weeks 0.8% (1.6%)
PDR 2003 [12]
Table 2: Renal data
15% Protein Diet 30% Protein Diet
Creatinine Clearance
(ml/min)
122 ± 11 113 ± 27
Microalbumin (mg) 7.8 ± 1.7 7.0 ± 0.8
Table 3: Lipid data
15% Protein
Diet
30% Protein
Diet
Total Cholesterol (mg/dl) 181 ± 15 171 ± 12
HDL-Cholesterol (mg/dl) 38 ± 3 39 ± 3
LDL-Cholesterol (mg/dl) 100 ± 12 101 ± 12
Triacylglycerol (mg/dl) 199 ± 20 161 ± 21*
* P < 0.05
%tGHb response in 12 subjects with type 2 diabetes at weekly intervals while ingesting a 15% or a 30% protein dietFigure 8
%tGHb response in 12 subjects with type 2 diabetes
at weekly intervals while ingesting a 15% or a 30%
protein diet. (From [10])
Publish with BioMed Central and every
scientist can read your work free of charge
"BioMed Central will be the most significant development for
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Nutrition & Metabolism 2004, 1:6 http://www.nutritionandmetabolism.com/content/1/1/6
Page 7 of 7
(page number not for citation purposes)
Competing interests
None declared.
Authors' contributions
Both authors were equally responsible for designing the
experiments, evaluating the statistics, interpreting the
data, writing the manuscript, and organizing the figures
and tables.
Acknowledgements
We would like to acknowledge the American Diabetes Association, the
Minnesota Beef Council, the Nebraska and Colorado Beef Councils for
financial support for these studies. Most importantly, we would like to
thank the volunteers who made the studies possible. We also would like to
thank Jennifer Nuttall Martenson, Kelly Jordan Schweim, Heidi Hoover,
Mary Adams, and the SDTU staff for their vital technical assistance in these
studies.
References
1. Janney NW: The metabolic relationship of the proteins to
glucose. J Biol Chem 1915, 20:321-350.
2. MacLean H: Modern Methods in the Diagnosis and Treatment
of Glycosuria and Diabetes. Volume 2nd edition. London, Consta-
ble & Co. Ltd.; 1924:1-52.
3. Conn JW, Newburgh LH: The glycemic response to isogluco-
genic quantities of protein and carbohydrate. J Clin Invest 1936,
15:665-671.
4. Joslin EP: Diabetic Manual of the Doctor and Patient. Philadel-
phia, Lea & Febinger; 1945.
5. Nuttall FQ, Mooradian AD, Gannon MC, Billington CJ, Krezowski PA:
Effect of protein ingestion on the glucose and insulin
response to a standardized oral glucose load. Diabetes Care
1984, 7:465-470.
6. Krezowski PA, Nuttall FQ, Gannon MC, Bartosh NH: The effect of
protein ingestion on the metabolic response to oral glucose
in normal individuals. Am J Clin Nutr 1986, 44:847-856.
7. Berger S, Vongaraya M: Insulin response to ingested protein in
diabetes. Diabetes 1966, 15:303-306.
8. Fajans SS, Floyd JC, Pek S, Knopf RF, Jacobson M, Conn JW: Effect of
protein meals on plasma insulin in mildly diabetic patients.
(Abstract #1). Diabetes 1968, 17:297.
9. Gannon MC, Nuttall FQ, Neil BJ, Westphal SA: The insulin and glu-
cose responses to meals of glucose plus various proteins in
type 2 diabetic subjects. Metabolism 1988, 37:1081-1088.
10. Gannon MC, Nuttall FQ, Saeed A, Jordan K, Hoover K: An increase
in dietary protein improves the blood glucose response in
people with type 2 diabetes. Amer J Clin Nutr 2003, 78:734-741.
11. Rech ME: Observations on the decay of glycated hemoglobin
HbA1c in diabetic patients. Exp Clin Endocrinol Diabetes 1996,
104:102-105.
12. Physicians' Desk Reference [http://www.PDR.net
]
13. Gannon MC, Nuttall FQ: Effect of a high-protein, low-carbohy-
drate diet on blood glucose control in people with type 2
diabetes. Diabetes 2004, 53:2375-2382.
... Even in people without diabetes, increased GV is a predictor of cardiovascular complications (20). Several studies showed that glycemic control in T2D can be improved by the dietary reduction of total carbohydrate intake, especially of high glycemic index carbohydrates and added sugars (21)(22)(23). This effect appears to be mediated, at least partly, by the reduction of PPG. ...
... Our initial hypothesis was based on two expectations: (i) Calorie deficit due to the reduced free sugar consumption and corresponding weight loss would improve glycemic control, and (ii) free sugar reduction would decrease PPG peaks and, in this way, improve glycemic variation. The last expectation resulted from the literature on the beneficial effects of reducing total carbohydrates and added sugars intake of subjects with T2D (21)(22)(23)(24). Study subjects did not have diabetes, but some of them were obese or overweight and showed prediabetes accordingly to the baseline HbA1c values. ...
Article
Full-text available
Background The Western diet, especially beverages and high processed food products, is high in sugars which are associated with the development of obesity and diabetes. The reduction of refined carbohydrates including free and added sugars improves glycemic control in individuals with diabetes, but the data regarding effects in subjects without diabetes are limited. Objective This study aimed to evaluate the effects of reducing free sugar intake on 24-h glucose profiles and glycemic variability using continuous glucose monitoring (CGM). Methods In the randomized controlled study, 21 normal weight and overweight/obese subjects (BMI 18–40 kg/m ² ) without diabetes were assigned to a 4-week reduced-sugar (RS) diet or control diet after a 2-week baseline phase. During the baseline phase, all participants were advised not to change their habitual diet. During the intervention phase, RS participants were asked to avoid added sugar and white flour products, whereas participants of the control group were requested to proceed their habitual diet. Anthropometric parameters and HbA1c were assessed before and at the end of the intervention phase. Interstitial glucose was measured using continuous glucose monitoring (CGM), and the food intake was documented by dietary records for 14 consecutive days during the baseline phase and for the first 14 consecutive days during the intervention phase. Mean 24-h glucose as well as intra- and inter-day indices of glucose variability, i.e., standard deviation (SD) around the sensor glucose level, coefficient of variation in percent (CV), mean amplitude of glucose excursions (MAGE), continuous overlapping net glycemic action (CONGA), and mean absolute glucose (MAG), were calculated for the baseline and intervention phases. Results During the intervention, the RS group decreased the daily intake of sugar (i.e., −22.4 ± 20.2 g, −3.28 ± 3.61 EN %), total carbohydrates (−6.22 ± 6.92 EN %), and total energy intake (−216 ± 108 kcal) and increased the protein intake (+2.51 ± 1.56 EN %) compared to the baseline values, whereby this intervention-induced dietary changes differed from the control group. The RS group slightly reduced body weight (−1.58 ± 1.33 kg), BMI, total fat, and visceral fat content and increased muscle mass compared to the baseline phase, but these intervention-induced changes showed no differences in comparison with the control group. The RS diet affected neither the 24-h mean glucose levels nor intra- and inter-day indices of glucose variability, HbA1c, or diurnal glucose pattern in the within- and between-group comparisons. Conclusion The dietary reduction of free sugars decreases body weight and body fat which may be associated with reduced total energy intake but does not affect the daily mean glucose and glycemic variability in individuals without diabetes. Clinical trial registration German Clinical Trials Register (DRKS); identifier: DRKS00026699.
... Protein intake also affects glycaemia as, similarly to fat, its ingestion slows down gastric emptying, and hence glucose release into the bloodstream [80]. With research being inconclusive as to the ideal amount of dietary protein to optimise glycaemic control and/or cardiovascular disease risk in DM, protein intake goals should follow that of the general population (10-15% of total energy intake) [77,81] or there may be the need for them to be individualised in certain cases [75]. ...
... g/kg/day; ~ 20% of total energy intake) as did the control group, yet participants did not have albuminuria or reduced estimated glomerular filtration rate. It is worth noting that certain amount of protein consumed is converted into BG in the process of gluconeogenesis, nevertheless its effect on BG seems to be relatively small [80]. ...
Preprint
Full-text available
Type 1 diabetes (T1D) is associated with hyperglycaemia-induced hypoxia and inflammation. The study assessed the effects of a single high-intensity interval exercise (HIIE) on glycaemia (BG) and serum level of pro-inflammatory cytokines and an essential mediator of adaptive response to hypoxia in T1D patients. The macronutrients intake was also evaluated. Nine patients suffering from T1D for about 12 years and nine healthy individuals (CG) were enrolled and completed one session of HIIE at the intensity of 120% lactate threshold and duration of 4 x 5 min intermittent with 5 min rest after each bout of exercise. Capillary and venous blood was withdrawn at rest, immediately after and at the 24 h post-HIIE for analysis of BG, hypoxia-inducible factor alpha (HIF-1α), tumour necrosis factor alpha (TNF-α) and vascular-endothelial growth factor (VEGF). Pre-exercise BG was significantly higher in the T1D compared to the CG (p = 0.043). HIIE led to a significant decline in T1D patients’ BG (p = 0.027) and to a tendency for a lower BG at 24-h post-HIIE vs pre-HIIE. HIF-1α was significantly elevated in the T1D compared to CG and there was a trend for HIF-1α to decline, and VEGF, TNF-α to increase in response to HIIE in the T1D group. Both groups consumed higher and lower than recommended amounts of protein and fat, respectively. In T1D group, a tendency for a higher digestible carbohydrate intake and more frequent hyperglycaemic episodes on the day after HIIE were observed. HIIE was effective in reducing T1D patients’ glycaemia and improving the short-term glycaemic control. HIIE has the potential to improve adaptive response to hypoxia by elevating the serum level of VEGF. Patients’ diet and level of physical activity should be screened on a regular basis, and they should be educated on the glycaemic effects of digestible carbohydrates.
... Nonetheless, plasma insulin levels did not significantly increase in either group. The literature contains conflicting results for interventions involving high-protein diets [61][62][63]. While fasting glucose decreased in the IG, no significant changes were observed in either group. ...
Article
Full-text available
Purpose Protein supplementation has been proposed as an effective dietary strategy for maintaining or increasing skeletal muscle mass and improving physical performance in middle-aged and older adults. Diabetes mellitus exacerbates muscle mass loss, leading to many older adults with type 2 diabetes mellitus (T2DM) experiencing sarcopenia, and vice versa. Our objective was to assess the impact of increased dietary protein intake on muscle mass, strength, physical performance, and the progression of T2DM in middle-aged and older adults diagnosed with this condition. Methods A 12-week randomized, controlled, parallel pilot study was conducted with 26 patients diagnosed with T2DM and had either low muscle mass, or low muscle strength or poor physical performance (age > 55 years old), aiming to investigate the effects of a protein-rich diet in sarcopenic and metabolic markers. The control group received 0.8–1.0 g/kg/day, while the intervention group received 1.2–1.5 g/kg/day of protein respectively. Body composition, muscle mass/strength and biochemical parameters were measured before and after the intervention period. Results Different kinetics of skeletal muscle index (SMI), appendicular lean mass (ALM), hand grip strength (HGS), gait speed (GS) and standing balance (SB) (p < 0.05) were observed between two groups. Specifically, the intervention group showed a significant improvement in HGS (p < 0.001) and physical performance (timed-up-and-go, p < 0.001; GS, p = 0.011; SB, p = 0.022), while the control group had its ALM (p = 0.014), SMI (p = 0.011) and HGS (p = 0.011) significantly reduced. The kinetics of metabolic markers indices was similar for both groups. Conclusion Current recommendation for protein intake (0.8–1 g/kg/day) is certainly not enough to ameliorate the muscle mass loss in middle age and older adults’ individuals with T2DM. In contrast, protein intake of 1.2–1.5 g/kg/day seems to be a more appropriate recommendation to combat upcoming sarcopenia, nonetheless the progression of T2DM was not interrupted.
... A high-protein diet enhances satiety and fullness, aiding in appetite suppression. High-protein foods do not significantly increase blood glucose levels when consumed, making them safe for patients with diabetes [18,20]. The test biscuits had a protein content that was significantly higher than what is typically found in standard biscuits. ...
Article
Full-text available
The glycemic index (GI) is a measure that classifies carbohydrate-rich foods according to their impact on blood glucose levels. Foods with a low GI are digested and absorbed at a slower rate, leading to a gradual increase in blood sugar, which helps maintain steady energy levels and reduce the risk of chronic conditions like diabetes and cardiovascular disease. This study evaluated the GI of protein- and fiber-rich biscuits to determine their suitability as a low-GI food option. Using a randomized crossover design, participants aged 18–45 years with a body mass index of 18.5–22.9 kg/m² were instructed to consume both test and reference foods on separate occasions. Blood samples were collected at multiple time points post-consumption, and the GI was determined by calculating the incremental area under the curve (IAUC) for the test food and expressing it as a percentage of the reference food’s IAUC. The GI of the nutritionally formulated diabetic biscuits (test food) was estimated to be 54±2, classifying them as low-GI food. These biscuits led to a significant reduction in capillary blood glucose levels at several post-consumption intervals, supporting their potential as a dietary option for prediabetic and diabetic individuals. Our findings indicate that high-protein, high-fiber, low-GI biscuits may offer nutritional benefits for prediabetic and diabetic individuals by supporting blood glucose control. This study highlights the potential role of low-GI foods in diabetes management, emphasizes the importance of GI testing for foods aimed at glycemic control, and reinforces the need for transparent nutritional labeling to impact consumer choices.
... Promotes an adequate nutritional status from essential amino acids and protein synthesis [16] Renal dysfunction by increasing glomerular blood pressure and GFR * [33,95] ** Improves glycemic control by increasing the release of insulin and insulin sensitivity [17,30,31] Osteoporosis due to accelerated bone resorption and urinary excretion of calcium by renal acid load [33,96] Decreases body adiposity by increasing resting caloric expenditure [17][18][19] Metabolic acidosis caused by acid load from animal-based dietary sources [95] Decreases risk of obesity by improving satiety [20,33,34] Cardiovascular risk due to the formation of atherosclerotic plaques [97,98] Protein-derived leucine is known to act as a nutrient-signaling molecule in the brain [30,31]. It can directly access the MBH as it bypasses the blood-brain barrier (BBB), specifically in the arcuate nucleus (ARC). ...
Article
Full-text available
Diabetes is a metabolic disease with a high worldwide prevalence and an important factor in mortality and disability in the population. Complications can be reduced or prevented with lifestyle changes in physical activity, dietary habits, and smoking cessation. High-protein diets (HPDs, >30% or >1.0 g/Kg/day) decrease hyperglycemia in part due to their content of branched-chain amino acids (BCAAs), mainly leucine. Leucine (and other BCAAs) improve glucose metabolism by directly signaling in the medio-basal hypothalamus (MBH), increasing liver insulin sensitivity. To determine the effectiveness of an HPD to lower hyperglycemia, we analyzed the results of published clinical studies focusing on the levels of fasting plasma glucose and/or glycosylated hemoglobin (HbA1c) in patients with type 2 diabetes mellitus (T2DM). We carried out a systematic search for clinical studies using HPDs. We searched five databases (Scopus, Web of Science, PubMed, Epistemonikos, and Cochrane), collecting 179 articles and finally selecting 8 articles to analyze their results. In conclusion, HPDs are an effective alternative to reduce hyperglycemia in patients with T2DM, especially so-called Paleolithic diets, due to their higher-quality protein from animal and vegetal sources and their exclusion of grains, dairy products, salt, refined fats, and added sugars.
... Beyond its potential role in promoting diabetic nephropathy, elevated protein intake may also be associated with an increased risk of CVD; however, conflicting evidence from studies precludes the establishment of a definitive association [15,16]. In contrast to the notion that protein intake increases complications risk, high protein intake in T2D patients results in only minor increases in blood glucose, and protein requires less insulin for its metabolism, which in turn reduces insulin-induced lipogenesis and improves blood lipids [17][18][19]. ...
Article
Full-text available
Our knowledge about the connection between protein intake and diabetes-related complications comes largely from studies among those already diagnosed with type 2 diabetes (T2D). However, there is a lack of information on whether changing protein intake after diabetes diagnosis affects complications risk. We aimed to explore the association between protein intake (total, animal, and plant) and vascular complications in incident T2D patients considering pre-diagnosis intake and changes in intake after diagnosis. This prospective cohort study included 1064 participants from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort who developed T2D during follow-up (physician-verified). Dietary protein intake was measured with a food frequency questionnaire at baseline and follow-up. We included physician-reported incident diabetes complications (myocardial infarction, stroke, nephropathy, and neuropathy). A total of 388 participants developed complications, 82 macrovascular complications, and 343 microvascular complications. Substituting carbohydrates with protein showed a trend towards lower complications risk, although this association was not statistically significant (hazard ratio (HR) for 5% energy (E) substitution: 0.83; 95% confidence intervals (CI): 0.60–1.14). Increasing protein intake at the expense of carbohydrates after diabetes diagnosis was not associated with total and microvascular complications (HR for 5% E change substitution: 0.98; 95% CI: 0.89–1.08 and HR for 5% E change substitution: 1.02; 95% CI: 0.92–1.14, respectively). Replacing carbohydrates with protein did not elevate the risk of diabetes complications in incident T2D cases.
... Protein intake also affects glycaemia as, similarly to fat, its ingestion slows down gastric emptying, and hence glucose release into the bloodstream [83]. With research being inconclusive as to the ideal amount of dietary protein to optimise glycaemic control and/or cardiovascular disease risk in DM, protein intake goals should follow that of the general population (10-15% of total energy intake) [79,84], or thy may need to be individualised in certain cases [85]. Those with diabetic kidney disease should aim to consume no more than 0.8 g/kg body mass/day [85]. ...
Article
Full-text available
Type 1 diabetes (T1D) is associated with hyperglycaemia-induced hypoxia and inflammation. This study assessed the effects of a single bout of high-intensity interval exercise (HIIE) on glycaemia (BG) and serum level of pro-inflammatory cytokines, and an essential mediator of adaptive response to hypoxia in T1D patients. The macronutrient intake was also evaluated. Nine patients suffering from T1D for about 12 years and nine healthy individuals (CG) were enrolled and completed one session of HIIE at the intensity of 120% lactate threshold with a duration of 4 × 5 min intermittent with 5 min rests after each bout of exercise. Capillary and venous blood were withdrawn at rest, immediately after and at 24 h post-HIIE for analysis of BG, hypoxia-inducible factor alpha (HIF-1α), tumour necrosis factor alpha (TNF-α) and vascular-endothelial growth factor (VEGF). Pre-exercise BG was significantly higher in the T1D patients compared to the CG (p = 0.043). HIIE led to a significant decline in T1D patients’ BG (p = 0.027) and a tendency for a lower BG at 24 h post-HIIE vs. pre-HIIE. HIF-1α was significantly elevated in the T1D patients compared to CG and there was a trend for HIF-1α to decline, and for VEGF and TNF-α to increase in response to HIIE in the T1D group. Both groups consumed more and less than the recommended amounts of protein and fat, respectively. In the T1D group, a tendency for a higher digestible carbohydrate intake and more frequent hyperglycaemic episodes on the day after HIIE were observed. HIIE was effective in reducing T1D patients’ glycaemia and improving short-term glycaemic control. HIIE has the potential to improve adaptive response to hypoxia by elevating the serum level of VEGF. Patients’ diet and level of physical activity should be screened on a regular basis, and they should be educated on the glycaemic effects of digestible carbohydrates.
Article
The treatment of type 2 diabetes has been greatly aided by dietary changes. The practice of adopting a healthy diet has become increasingly popular around the world. In addition to assisting with the maintenance of appropriate blood sugar and blood pressure levels, this also helps to prevent long-term organ damage and enhances general health. In this analysis, we look at the research on high-protein and low-carbohydrate diets for diabetes patients with the goal of better glycemic control. To better understand the connection between type 2 diabetes and food, this study will examine the effects of a high-protein diet and a low-carbohydrate diet on blood sugar levels in persons with the disease.
Article
Diabetes mellitus is a condition caused by a deficiency in insulin production or sensitivity that is defined by persistent hyperglycemia as well as disturbances in glucose, lipid, and protein metabolism. Uncurbed diabetes or incessant hyperglycemic condition can lead to severe complications, including renal damage, visual impairment, cardiovascular disease, neuropathy, etc., which promotes diabetes-associated morbidity and mortality rates. The therapeutic management of diabetes includes conventional medications and nutraceuticals as complementary therapies. Nutraceuticals are bioactive compounds derived from food sources that have health-promoting properties and are instrumental in the management and treatment of various maladies. Nutraceuticals are clinically exploited to tackle DM pathogenesis, and the clinical evidence suggests that nutraceuticals can modulate biochemical parameters related to diabetes pathogenesis and comorbidities. Hypoglycemic medicines are designed to mitigate DM in traditional medicinal practice. This review intends to emphasize and comment on the various therapeutic strategies available to manage this chronic condition, conventional drugs, and the potential role of nutraceuticals in managing the complexity of the disease and reducing the risk of complications. In contrast to conventional antihyperglycemic drugs, nutraceutical supplements offer a higher efficacy and lesser adverse effects. To substantiate the efficacy and safety of various functional foods in conjunction with conventional hypoglycemic medicines, additional data from clinical studies are required.
Article
Full-text available
Eight normal subjects were given 50 g protein, 50 g glucose, or 50 g protein + 50 g glucose. Plasma glucose, insulin, C-peptide, glucagon, alpha-amino nitrogen (AAN), and nonesterified fatty acid (NEFA) responses were then determined over 4 h. Protein stimulated only a modest insulin rise and the area above fasting baseline was only 28% of that after glucose. The sum of the serum insulin area following protein ingestion and that following glucose ingestion was 100.4% of the combination meal. C-peptide changes confirmed the insulin response. The addition of glucose to the protein meal resulted in a 60 min delay in glucagon and AAN rise compared to the protein meal alone. Subsequently AAN and glucagon increased to levels greater than or equal to those observed after protein ingestion alone. In summary, protein is a much less potent secretagogue for insulin than is glucose in normal individuals, and the effect on insulin secretion is not synergistic. Addition of glucose to a protein meal results in a delayed rise in AAN and glucagon concentrations in normal subjects.
Article
Full-text available
Type II diabetic subjects were given 50 g protein, 50 g glucose, or 50 g glucose with 50 g protein as a single meal in random sequence. The plasma glucose and insulin response was determined over the subsequent 5 h. The plasma glucose area above the baseline following a glucose meal was reduced 34% when protein was given with the glucose. When protein was given alone, the glucose concentration remained stable for 2 h and then declined. The insulin area following glucose was only modestly greater than with a protein meal (97 +/- 35, 83 +/- 19 microU X h/ml, respectively). When glucose was given with protein, the mean insulin area was considerably greater than when glucose or protein was given alone (247 +/- 33 microU X h/ml). When various amounts of protein were given with 50 g glucose, the insulin area response was essentially first order. Subsequently, subjects were given 50 g glucose or 50 g glucose with 50 g protein as two meals 4 h apart in random sequence. The insulin areas were not significantly different for each meal but were higher when protein + glucose was given. After the second glucose meal the plasma glucose area was 33% less than after the first meal. Following the second glucose + protein meal the plasma glucose area was markedly reduced, being only 7% as large as after the first meal. These data indicate that protein given with glucose will increase insulin secretion and reduce the plasma glucose rise in at least some type II diabetic persons.
Article
Full-text available
In single-meal studies, dietary protein does not result in an increase in glucose concentrations in persons with or without type 2 diabetes, even though the resulting amino acids can be used for gluconeogenesis. The metabolic effects of a high-protein diet were compared with those of the prototypical healthy (control) diet, which is currently recommended by several scientific organizations. The metabolic effects of both diets, consumed for 5 wk each (separated by a 2-5-wk washout period), were studied in 12 subjects with untreated type 2 diabetes. The ratio of protein to carbohydrate to fat was 30:40:30 in the high-protein diet and 15:55:30 in the control diet. The subjects remained weight-stable during the study. With the fasting glucose concentration used as a baseline from which to determine the area under the curve, the high-protein diet resulted in a 40% decrease in the mean 24-h integrated glucose area response. Glycated hemoglobin decreased 0.8% and 0.3% after 5 wk of the high-protein and control diets, respectively; the difference was significant (P < 0.05). The rate of change over time was also significantly greater after the high-protein diet than after the control diet (P < 0.001). Fasting triacylglycerol was significantly lower after the high-protein diet than after the control diet. Insulin, C-peptide, and free fatty acid concentrations were not significantly different after the 2 diets. A high-protein diet lowers blood glucose postprandially in persons with type 2 diabetes and improves overall glucose control. However, longer-term studies are necessary to determine the total magnitude of response, possible adverse effects, and the long-term acceptability of the diet.
Article
Full-text available
There has been interest in the effect of various types and amounts of dietary carbohydrates and proteins on blood glucose. On the basis of our previous data, we designed a high-protein/low-carbohydrate, weight-maintaining, nonketogenic diet. Its effect on glucose control in people with untreated type 2 diabetes was determined. We refer to this as a low-biologically-available-glucose (LoBAG) diet. Eight men were studied using a randomized 5-week crossover design with a 5-week washout period. The carbohydrate:protein:fat ratio of the control diet was 55:15:30. The test diet ratio was 20:30:50. Plasma and urinary beta-hydroxybutyrate were similar on both diets. The mean 24-h integrated serum glucose at the end of the control and LoBAG diets was 198 and 126 mg/dl, respectively. The percentage of glycohemoglobin was 9.8 +/- 0.5 and 7.6 +/- 0.3, respectively. It was still decreasing at the end of the LoBAG diet. Thus, the final calculated glycohemoglobin was estimated to be approximately 6.3-5.4%. Serum insulin was decreased, and plasma glucagon was increased. Serum cholesterol was unchanged. Thus, a LoBAG diet ingested for 5 weeks dramatically reduced the circulating glucose concentration in people with untreated type 2 diabetes. Potentially, this could be a patient-empowering way to ameliorate hyperglycemia without pharmacological intervention. The long-term effects of such a diet remain to be determined.
Article
We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients. A synergistic effect was seen when given with glucose. Therefore, we considered it important to determine if other common dietary proteins also strongly stimulate an increase in insulin concentration when given with glucose. Seventeen type II (non-insulin-dependent) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose, or 50 g glucose plus 25 g protein in the form of lean beef, turkey, gelatin, egg white, cottage cheese, fish, or soy. The peripheral plasma concentrations of glucose, insulin, glucagon, alpha amino nitrogen, urea nitrogen, free fatty acids, and triglycerides were measured. Following ingestion of the meals containing protein, the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone. The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese (360%) and was least with egg white (190%) compared with that following glucose alone (100%). The glucose response was diminished following ingestion of the meals containing protein with the exception of the egg white meals. The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein. The alpha amino nitrogen concentration varied considerably. It was decreased after glucose alone, was unchanged after egg white ingestion, and was greatest after ingestion of gelatin. The free fatty acid concentration decrease was 4- to 8-fold greater after the ingestion of protein with glucose compared with ingestion of glucose alone.
Article
We have reported that in mildly diabetic patients increases in plasma insulin are subnormal in response to infused amino acids while others have reported excessive increases in response to ingested protein. Increases in plasma insulin exhibited by nonobese, mildly diabetic patients in response to the ingest ion of protein meals and to the intravenous administration of a mixture of ten essential amino acids were compared to those of healthy nonobese control subjects. The plasma insulin responses to protein meals were also determined in a group of mildly obese, mildly diabetic patients. The results of these studies indicate that: (1) the mean insulin response of nonobese mildly diabetic patients to protein meals is subnormal and not excessive, (2) mildly obese, mildly diabetic patients respond excessively to protein meals as compared to control subjects of normal weight, and (3) the excessiye insulin response to protein meals reported by others to occur in diabetics is probably the result of a greater degree of adiposity in their diabetics than in their control subjects, rather than of the presence of diabetes mellitus. Unless the degree of adiposity is similar in diabetic and healthy subjects, meaningful comparison of their insulin responses to protein meals or other stimuli cannot be made.
Article
The ingestion of protein by normal human subjects has been shown recently to represent a stimulus to the secretion of insulin. This response is probably related to the postprandial rise in plasma amino acid concentration. Since disordered protein synthesis may contribute to the pathogenesis of diabetes and its complications, the insulin response to ingested protein (casein or gelatin, 50-100 gm.) was compared in twenty-eight normals and ten maturity-onset diabetics. Insulin response (microunits-minutes, μU.-min.) was considered to be the area included by that portion of the plasma insulin response curve above projected basal insulin secretion. Following protein ingestion the diabetics showed a mean insulin response (± S.E.M.) of 3,425 ± 367 μU.-min., compared with 1,005 ± 136 in the normals, a 3.4-fold difference (p < 0.01). In neither group were there significant or consistent changes in plasma glucose concentration. The fall in free fatty acids was comparable and no difference was seen in the plasma amino acid nitrogen curves. These data indicate that the insulin response to ingested protein is excessive in diabetes. The mechanism of the hyperresponse would seem to lie within the beta cell since no abnormality of the presumed amino acid stimulus was demonstrated.
Article
In 44 diabetic patients, who within 7 days lowered their average glycemia by 140 to 220 mg % and kept it at this level over a mean of 36 days, HbA1c was measured repeatedly by HPLC (normal range 4.2-5.6% of total hemoglobin). Thereby, the maximum decay rate of HbA1c could be observed in vivo as being 0.1% per day which is consistent with previous theoretical considerations by other authors. Some clinical implications that this finding may have for diabetic patients are being discussed.
Diabetic Manual of the Doctor and Patient. Philadel-phia, Lea & Febinger
  • Joslin
  • Ep
Joslin EP: Diabetic Manual of the Doctor and Patient. Philadel-phia, Lea & Febinger; 1945.